BDNF and prostate carcinoma: In prostate cancer [53], the development of NGF/NTRK1 or BDNF/NTRK2 autocrine signaling pathways is an escape mechanism, from both the androgen control and the paracrine dependence of stromal cells produced neurotrophins.